Recent Advances and Future Perspectives of Subarachnoid Hemorrhage

Dear Colleagues,

Subarachnoid hemorrhage is a potentially life-threatening type of brain hemorrhage of which around 22–26% of patients die before reaching a hospital and many suffer from permanent neurological deficits, in many cases requiring permanent care at home. It affects around 6.1/100,000 person-years, and the average age of patients affected is between 50 and 60 years old. Although the outcome of patients has improved over time, the overall 30-day mortality is around 35%. The most common cause is the rupture of intracranial aneurysms followed by the rupture of AVMs or arteriovenous fistulas.

In this Special Issue we aim to focus on neurocritical aspects and future treatment options of patients with subarachnoid hemorrhage in order to improve functional outcomes, adhering to the current guidelines. Our vision is to continue evolving by implementing new monitoring options and therapeutic strategies, from confirming the cause of a subarachnoid hemorrhage to managing its complications.

Topics will include the following:

• Neuromonitoring.
• Pharmacological or interventional treatments of complications such as delayed cerebral ischemia and delayed neurological deficits.

Dr. Alexandros Doukas
Prof. Dr. Athanasios K. Petridis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.